Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia...
43 KB (3,613 words) - 02:13, 16 July 2024
(tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib). In 2013, Novartis acquired Incyte's c-Met...
11 KB (763 words) - 23:44, 7 October 2024
Remdesivir (section Remdesivir/baricitinib)
FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed...
112 KB (9,665 words) - 23:49, 14 October 2024
In June 2022, the U.S. Food and Drug Administration (FDA) authorized baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of severe alopecia...
43 KB (4,303 words) - 02:14, 9 September 2024
crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib...
5 KB (232 words) - 10:23, 8 March 2024
Administration (FDA) requires a boxed warning for the JAK inhibitors tofacitinib, baricitinib, and upadacitinib to warn about the risks of serious heart-related events...
37 KB (3,296 words) - 08:26, 12 October 2024
need systemic medicines such as cyclosporin, methotrexate, dupilumab or baricitinib. Other names of the condition include "infantile eczema", "flexural eczema"...
90 KB (9,344 words) - 04:02, 26 August 2024
Management of hair loss (section Baricitinib)
alopecia spironolactone and flutamide. In June 2022, the FDA authorized baricitinib for the treatment of severe alopecia areata. Minoxidil, applied topically...
68 KB (7,160 words) - 18:52, 24 February 2024
relative effectiveness of deuruxolitinib and another Janus kinase inhibitor—baricitinib—for alopecia areata may vary depending on the population studied, both...
9 KB (457 words) - 05:12, 6 October 2024
Later that month, the WHO recommended the rheumatoid arthritis drug Baricitinib for severe or critical patients. It also recommended the monoclonal antibody...
369 KB (32,753 words) - 01:19, 13 October 2024
"Bloomberg", February 9, 2017 Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase...
3 KB (156 words) - 10:21, 6 July 2024
which is in the public domain. "Frequently Asked Questions on Olumiant (Baricitinib) for the Treatment of COVID-19" (PDF). U.S. Food and Drug Administration...
128 KB (14,817 words) - 01:34, 9 September 2024
Spondyloenchondrodysplasia (section Baricitinib)
headaches didn't stop, she was then prescribed a 2–4 mg daily dose of baricitinib, the latter medication significantly improved her serum ferritin levels...
27 KB (2,808 words) - 05:46, 8 April 2024
metaplasia with myelofibrosis and vitiligo. Examples are tofacitinib, baricitinib, upadacitinib and filgotinib. In 2014 researchers discovered that oral...
9 KB (974 words) - 14:46, 22 June 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
26 KB (2,203 words) - 06:19, 6 October 2024
(initiation) Intracellular (reception) Extracellular Unsorted Avacopan Baricitinib Bimekizumab Blisibimod Briakinumab Brodalumab Canakinumab Crovalimab...
7 KB (299 words) - 13:45, 27 April 2024
FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed...
174 KB (19,768 words) - 01:07, 18 September 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
33 KB (3,686 words) - 07:30, 20 May 2024
(PDE4) inhibitor tsDMARD azathioprine Purine synthesis inhibitor unknown baricitinib JAK1 and JAK2 inhibitor tsDMARD certolizumab pegol TNF inhibitor bDMARD...
10 KB (869 words) - 17:44, 20 August 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
35 KB (3,965 words) - 16:19, 27 September 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
24 KB (1,710 words) - 19:18, 30 August 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
31 KB (3,430 words) - 05:24, 28 August 2024
2022, the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib) for adults with severe alopecia areatal. It is the first FDA approved...
48 KB (5,563 words) - 21:02, 15 October 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
62 KB (7,065 words) - 05:17, 28 June 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
12 KB (705 words) - 02:49, 12 October 2024
Drug Administration (FDA) requires a boxed warning for tofacitinib, baricitinib, and upadacitinib to include information about the risks of serious heart-related...
46 KB (4,534 words) - 22:58, 20 August 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
20 KB (2,259 words) - 11:36, 29 July 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
62 KB (6,845 words) - 05:57, 16 October 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
23 KB (2,087 words) - 09:12, 24 August 2024
JAK1 Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod...
26 KB (2,102 words) - 02:19, 16 July 2024